XML 54 R36.htm IDEA: XBRL DOCUMENT
v3.26.1

Concentration of Risks | 12 Months Ended
--- | ---
Dec. 31, 2025
Risks and Uncertainties [Abstract] |
Concentration of Risks | Note 26. Concentration of Risks Our current operations subject us to the following concentrations of risk: Insurance Solutions Historically, we have assumed our MYGA products, which is a part of our insurance operations, from two insurance companies, ACL and SSL. We have made a decision to no longer assume business from ACL and SSL as of June 30, 2024. However, the Company will continue to earn investment income from the cash proceeds of the existing MYGA contracts and the holders will continue to be a diversified base of numerous individuals. Effective March 31, 2025, Ability entered a new reinsurance treaty for additional MYGA with National Security Group (“NSG”), further diversifying its reinsurance partners. Certain concentrations of credit risk related to reinsurance recoverable exist with the insurance organizations listed in the table below:
As of December 31, 2025 |  | A.M. Best credit rating |  | Net reinsurance recoverable 1 |  | Funds withheld payable |  | Net reinsurance credit exposure
Medico Insurance Company |  | A |  | $ | 4,466 |  |  | $ | — |  |  | $ | 4,466 |
Front Street Re |  | Not Rated |  | 273,981 |  |  | 237,143 |  |  | 36,838 |
Vista Life and Casualty Reinsurance Co |  | Not Rated |  | 178,273 |  |  | 183,802 |  |  | 0 |
Total |  |  |  | $ | 456,720 |  |  | $ | 420,945 |  |  | $ | 41,304 |
As of December 31, 2024 |  | A.M. Best credit rating |  | Net reinsurance recoverable 1 |  | Funds withheld payable |  | Net reinsurance credit exposure
Medico Insurance Company |  | A |  | $ | 4,376 |  |  | $ | — |  |  | $ | 4,376 |
Front Street Re |  | Not Rated |  | 266,629 |  |  | 239,918 |  |  | 26,711 |
Vista Life and Casualty Reinsurance Co |  | Not Rated |  | 179,220 |  |  | 190,771 |  |  | — |
Total |  |  |  | $ | 450,225 |  |  | $ | 430,689 |  |  | $ | 31,087 |
_______________ (1)Includes credit loss allowance of $1.1 million and $0.8 million as of December 31, 2025 and December 31, 2024, respectively, held against reinsurance recoverable. Further, our Insurance Solutions segment has the following investment concentration risk:
|  | As of December 31, 2025
|  | Fair value |  | % of total
Insurance Solutions |  |  |  |
United States |  | $ | 688,545 |  |  | 72 | %
Cayman Islands |  | 207,034 |  |  | 22 | %
Other¹ |  | 61,229 |  |  | 6 | %
Total insurance solutions |  | 956,808 |  |  | 100 | %
Insurance Solutions consolidated VIEs |  |  |  |
United States |  | 111,781 |  |  | 93 | %
Other² |  | 8,899 |  |  | 7 | %
Total insurance solutions consolidated VIEs |  | 120,680 |  |  | 100 | %
Total |  | $ | 1,077,488 |  |  |
_______________ (1)Other consists of nominal investments primarily in Bermuda, Canada, Cayman Islands and United Kingdom. (2)Other consists of nominal investments primarily in Ireland and Canada.
|  | As of December 31, 2024
|  | Fair value |  | % of total
Insurance Solutions |  |  |  |
United States |  | $ | 643,438 |  |  | 70 | %
Canada |  | 6,579 |  |  | 1 | %
Other¹ |  | 265,539 |  |  | 29 | %
Total insurance solutions |  | 915,556 |  |  | 100 | %
Insurance Solutions consolidated VIEs |  |  |  |
United States |  | 120,144 |  |  | 95 | %
Canada |  | 1,075 |  |  | 1 | %
Other |  | 4,679 |  |  | 4 | %
Total insurance solutions consolidated VIEs |  | 125,898 |  |  | 100 | %
Total |  | $ | 1,041,454 |  |  |
_______________ (1)Other consists of nominal investments primarily in Cayman Islands, Bermuda, and United Kingdom. The Asset Management segment does not have meaningful investment concentration risk.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (d)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (d)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 3A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482836/275-10-55-3A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-2A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration